HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-MAY-12 4F65
TITLE CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE
TITLE 2 DOMAIN IN COMPLEX WITH COMPOUND 8
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 458-765);
COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR,
COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE C-
COMPND 7 FGR;
COMPND 8 EC: 2.7.10.1;
COMPND 9 ENGINEERED: YES;
COMPND 10 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS KINASE, ATP BINDING, PHOSPHORYLATION, TRANS-MEMBRANE, TRANSFERASE-
KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR R.A.NORMAN,J.BREED,D.OGG
REVDAT 3 28-FEB-24 4F65 1 REMARK SEQADV
REVDAT 2 27-JUN-12 4F65 1 JRNL
REVDAT 1 06-JUN-12 4F65 0
JRNL AUTH R.A.NORMAN,A.K.SCHOTT,D.M.ANDREWS,J.BREED,K.M.FOOTE,
JRNL AUTH 2 A.P.GARNER,D.OGG,J.P.ORME,J.H.PINK,K.ROBERTS,D.A.RUDGE,
JRNL AUTH 3 A.P.THOMAS,A.G.LEACH
JRNL TITL PROTEIN-LIGAND CRYSTAL STRUCTURES CAN GUIDE THE DESIGN OF
JRNL TITL 2 SELECTIVE INHIBITORS OF THE FGFR TYROSINE KINASE.
JRNL REF J.MED.CHEM. V. 55 5003 2012
JRNL REFN ISSN 0022-2623
JRNL PMID 22612866
JRNL DOI 10.1021/JM3004043
REMARK 2
REMARK 2 RESOLUTION. 2.26 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.1
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.95
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7
REMARK 3 NUMBER OF REFLECTIONS : 29937
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.204
REMARK 3 R VALUE (WORKING SET) : 0.203
REMARK 3 FREE R VALUE : 0.236
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020
REMARK 3 FREE R VALUE TEST SET COUNT : 1504
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 15
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.34
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.72
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2302
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2266
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2197
REMARK 3 BIN R VALUE (WORKING SET) : 0.2252
REMARK 3 BIN FREE R VALUE : 0.2566
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.56
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 105
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4354
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 118
REMARK 3 SOLVENT ATOMS : 190
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 45.47
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.66
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 7.80110
REMARK 3 B22 (A**2) : -10.97320
REMARK 3 B33 (A**2) : 3.17210
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.51870
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.299
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.211
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.298
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.212
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 4560 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 6152 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1579 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 99 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 664 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 4560 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 572 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 5260 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.09
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.98
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.43
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 18.3125 0.9367 -2.3017
REMARK 3 T TENSOR
REMARK 3 T11: -0.0901 T22: -0.0549
REMARK 3 T33: -0.1575 T12: 0.0196
REMARK 3 T13: 0.0158 T23: 0.0031
REMARK 3 L TENSOR
REMARK 3 L11: 1.5325 L22: 0.7019
REMARK 3 L33: 2.1979 L12: -0.0629
REMARK 3 L13: 0.5600 L23: 0.1093
REMARK 3 S TENSOR
REMARK 3 S11: 0.0825 S12: 0.0114 S13: -0.0128
REMARK 3 S21: 0.0077 S22: -0.1240 S23: -0.0625
REMARK 3 S31: 0.2579 S32: -0.0345 S33: 0.0415
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: { B|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 59.4439 -0.9064 22.6107
REMARK 3 T TENSOR
REMARK 3 T11: -0.0899 T22: -0.1302
REMARK 3 T33: -0.0796 T12: 0.0109
REMARK 3 T13: 0.0069 T23: -0.0037
REMARK 3 L TENSOR
REMARK 3 L11: 2.1138 L22: 0.8154
REMARK 3 L33: 2.0037 L12: -0.2417
REMARK 3 L13: 1.0903 L23: -0.5381
REMARK 3 S TENSOR
REMARK 3 S11: -0.0529 S12: -0.1886 S13: -0.0005
REMARK 3 S21: 0.0824 S22: 0.0594 S23: 0.1330
REMARK 3 S31: -0.0866 S32: 0.0304 S33: -0.0065
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4F65 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-12.
REMARK 100 THE DEPOSITION ID IS D_1000072503.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-FEB-11
REMARK 200 TEMPERATURE (KELVIN) : 110
REMARK 200 PH : 6.25-7.25
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30388
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.259
REMARK 200 RESOLUTION RANGE LOW (A) : 100.929
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2
REMARK 200 DATA REDUNDANCY : 2.300
REMARK 200 R MERGE (I) : 0.04100
REMARK 200 R SYM (I) : 0.02700
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38
REMARK 200 COMPLETENESS FOR SHELL (%) : 80.2
REMARK 200 DATA REDUNDANCY IN SHELL : 1.90
REMARK 200 R MERGE FOR SHELL (I) : 0.27000
REMARK 200 R SYM FOR SHELL (I) : 0.21300
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.700
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 48.19
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 16-20% PEG8000, 100 MM PCTP, 100-300
REMARK 280 MM AMMONIUM SULFATE, 25% ETHYLENE GLYCOL, PH 6.25-7.25, VAPOR
REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 105.35650
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.18250
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 105.35650
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.18250
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 457
REMARK 465 ALA A 458
REMARK 465 GLY A 459
REMARK 465 VAL A 460
REMARK 465 SER A 461
REMARK 465 GLU A 462
REMARK 465 TYR A 463
REMARK 465 LYS A 502
REMARK 465 ASP A 503
REMARK 465 GLY A 580
REMARK 465 LEU A 581
REMARK 465 GLU A 582
REMARK 465 TYR A 583
REMARK 465 SER A 584
REMARK 465 TYR A 585
REMARK 465 ASN A 586
REMARK 465 PRO A 587
REMARK 465 SER A 588
REMARK 465 HIS A 589
REMARK 465 ASN A 590
REMARK 465 GLY A 643
REMARK 465 LEU A 644
REMARK 465 ALA A 645
REMARK 465 ARG A 646
REMARK 465 ASP A 647
REMARK 465 ILE A 648
REMARK 465 HIS A 649
REMARK 465 HIS A 650
REMARK 465 ILE A 651
REMARK 465 ASP A 652
REMARK 465 GLY B 457
REMARK 465 ALA B 458
REMARK 465 GLY B 459
REMARK 465 LYS B 502
REMARK 465 ASP B 503
REMARK 465 LYS B 504
REMARK 465 PRO B 579
REMARK 465 GLY B 580
REMARK 465 LEU B 581
REMARK 465 GLU B 582
REMARK 465 TYR B 583
REMARK 465 SER B 584
REMARK 465 TYR B 585
REMARK 465 ASN B 586
REMARK 465 PRO B 587
REMARK 465 SER B 588
REMARK 465 HIS B 589
REMARK 465 ASN B 590
REMARK 465 PRO B 591
REMARK 465 GLU B 592
REMARK 465 GLU B 593
REMARK 465 GLY B 643
REMARK 465 LEU B 644
REMARK 465 ALA B 645
REMARK 465 ARG B 646
REMARK 465 ASP B 647
REMARK 465 ILE B 648
REMARK 465 HIS B 649
REMARK 465 GLN B 764
REMARK 465 GLU B 765
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 464 CG CD OE1 OE2
REMARK 470 GLU A 486 CG CD OE1 OE2
REMARK 470 ASP A 501 CG OD1 OD2
REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 517 CE NZ
REMARK 470 SER A 518 OG
REMARK 470 ASP A 519 OD1 OD2
REMARK 470 GLU A 522 CD OE1 OE2
REMARK 470 LYS A 523 CD CE NZ
REMARK 470 LYS A 542 CE NZ
REMARK 470 TYR A 653 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 LYS A 655 CE NZ
REMARK 470 ARG A 675 NE CZ NH1 NH2
REMARK 470 GLU A 707 CG CD OE1 OE2
REMARK 470 LYS A 714 NZ
REMARK 470 ASN A 724 CG OD1 ND2
REMARK 470 LYS A 748 CE NZ
REMARK 470 SER A 762 OG
REMARK 470 ARG B 477 NH1
REMARK 470 ASP B 501 CG OD1 OD2
REMARK 470 ASN B 506 CG OD1 ND2
REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2
REMARK 470 LYS B 510 NZ
REMARK 470 LYS B 523 CD CE NZ
REMARK 470 LYS B 618 CE NZ
REMARK 470 HIS B 650 CB CG ND1 CD2 CE1 NE2
REMARK 470 LYS B 655 CD CE NZ
REMARK 470 ASN B 659 ND2
REMARK 470 ASP B 674 OD1
REMARK 470 GLU B 707 CG CD OE1 OE2
REMARK 470 LYS B 711 CD CE NZ
REMARK 470 LYS B 714 CE NZ
REMARK 470 ASP B 720 CG OD1 OD2
REMARK 470 ASN B 727 OD1
REMARK 470 MET B 731 CG SD CE
REMARK 470 ASN B 763 CG OD1 ND2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PHE A 489 -2.73 76.03
REMARK 500 ARG A 622 -13.80 69.63
REMARK 500 ASP A 623 42.01 -142.17
REMARK 500 SER B 461 46.10 -97.90
REMARK 500 ASP B 468 89.72 -158.13
REMARK 500 PHE B 489 -4.74 76.13
REMARK 500 ARG B 622 -12.90 62.62
REMARK 500 ASN B 724 -8.93 75.40
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 801
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 802
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 803
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 804
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 805
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 807
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0S9 A 808
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 801
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 802
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 804
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 805
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 806
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 807
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0S9 B 808
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4F63 RELATED DB: PDB
REMARK 900 RELATED ID: 4F64 RELATED DB: PDB
DBREF 4F65 A 458 765 UNP P11362 FGFR1_HUMAN 458 765
DBREF 4F65 B 458 765 UNP P11362 FGFR1_HUMAN 458 765
SEQADV 4F65 GLY A 457 UNP P11362 EXPRESSION TAG
SEQADV 4F65 ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION
SEQADV 4F65 SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION
SEQADV 4F65 GLY B 457 UNP P11362 EXPRESSION TAG
SEQADV 4F65 ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION
SEQADV 4F65 SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION
SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO
SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS
SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA
SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL
SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR
SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET
SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU
SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE
SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU
SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN
SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP
SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU
SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA
SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS
SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE
SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL
SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR
SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU
SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY
SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY
SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU
SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER
SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP
SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU
SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO
SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS
SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA
SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL
SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR
SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET
SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU
SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE
SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU
SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN
SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP
SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU
SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA
SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS
SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE
SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL
SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR
SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU
SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY
SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY
SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU
SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER
SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP
SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU
HET SO4 A 801 5
HET SO4 A 802 5
HET EDO A 803 4
HET EDO A 804 4
HET EDO A 805 4
HET EDO A 806 4
HET EDO A 807 4
HET 0S9 A 808 29
HET SO4 B 801 5
HET SO4 B 802 5
HET EDO B 803 4
HET EDO B 804 4
HET EDO B 805 4
HET EDO B 806 4
HET EDO B 807 4
HET 0S9 B 808 29
HETNAM SO4 SULFATE ION
HETNAM EDO 1,2-ETHANEDIOL
HETNAM 0S9 5-BROMO-N~2~-[(3-METHYL-1,2-OXAZOL-5-YL)METHYL]-N~4~-
HETNAM 2 0S9 [3-(2-PHENYLETHYL)-1H-PYRAZOL-5-YL]PYRIMIDINE-2,4-
HETNAM 3 0S9 DIAMINE
HETSYN EDO ETHYLENE GLYCOL
FORMUL 3 SO4 4(O4 S 2-)
FORMUL 5 EDO 10(C2 H6 O2)
FORMUL 10 0S9 2(C20 H20 BR N7 O)
FORMUL 19 HOH *190(H2 O)
HELIX 1 1 PRO A 474 ASP A 476 5 3
HELIX 2 2 THR A 521 GLY A 539 1 19
HELIX 3 3 ASN A 568 ALA A 575 1 8
HELIX 4 4 SER A 596 LYS A 617 1 22
HELIX 5 5 ALA A 625 ARG A 627 5 3
HELIX 6 6 LEU A 662 MET A 667 5 6
HELIX 7 7 ALA A 668 ARG A 675 1 8
HELIX 8 8 THR A 678 THR A 695 1 18
HELIX 9 9 PRO A 705 GLU A 715 1 11
HELIX 10 10 THR A 726 TRP A 737 1 12
HELIX 11 11 VAL A 740 ARG A 744 5 5
HELIX 12 12 THR A 746 THR A 761 1 16
HELIX 13 13 PRO B 474 ASP B 476 5 3
HELIX 14 14 THR B 521 GLY B 539 1 19
HELIX 15 15 ASN B 568 ALA B 575 1 8
HELIX 16 16 SER B 596 LYS B 617 1 22
HELIX 17 17 ALA B 625 ARG B 627 5 3
HELIX 18 18 LEU B 662 MET B 667 5 6
HELIX 19 19 ALA B 668 ARG B 675 1 8
HELIX 20 20 THR B 678 THR B 695 1 18
HELIX 21 21 PRO B 705 GLU B 715 1 11
HELIX 22 22 THR B 726 TRP B 737 1 12
HELIX 23 23 VAL B 740 ARG B 744 5 5
HELIX 24 24 THR B 746 THR B 761 1 16
SHEET 1 A 5 LEU A 478 GLY A 487 0
SHEET 2 A 5 GLY A 490 ILE A 498 -1 O LEU A 494 N LYS A 482
SHEET 3 A 5 VAL A 508 MET A 515 -1 O MET A 515 N GLN A 491
SHEET 4 A 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514
SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560
SHEET 1 B 2 VAL A 629 VAL A 631 0
SHEET 2 B 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630
SHEET 1 C 5 LEU B 478 GLY B 487 0
SHEET 2 C 5 GLY B 490 ILE B 498 -1 O LEU B 494 N LYS B 482
SHEET 3 C 5 VAL B 508 MET B 515 -1 O MET B 515 N GLN B 491
SHEET 4 C 5 TYR B 558 GLU B 562 -1 O VAL B 559 N LYS B 514
SHEET 5 C 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560
SHEET 1 D 2 VAL B 629 VAL B 631 0
SHEET 2 D 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630
CISPEP 1 VAL B 460 SER B 461 0 -0.29
SITE 1 AC1 6 ARG A 470 TRP A 471 GLU A 472 LEU A 500
SITE 2 AC1 6 LEU A 548 EDO A 807
SITE 1 AC2 4 GLY A 539 LYS A 540 LYS A 618 HOH A 957
SITE 1 AC3 4 ARG A 470 LYS A 618 HIS A 679 HOH A 963
SITE 1 AC4 5 GLN A 574 ARG A 577 GLY A 697 GLY A 698
SITE 2 AC4 5 SER A 699
SITE 1 AC5 4 ALA A 615 PHE A 747 LYS A 748 HOH A 974
SITE 1 AC6 2 ARG A 470 SO4 A 801
SITE 1 AC7 17 LEU A 484 GLU A 486 GLY A 487 VAL A 492
SITE 2 AC7 17 ALA A 512 LYS A 514 GLU A 531 VAL A 561
SITE 3 AC7 17 GLU A 562 TYR A 563 ALA A 564 SER A 565
SITE 4 AC7 17 GLY A 567 ARG A 627 LEU A 630 HOH A 969
SITE 5 AC7 17 HOH A 993
SITE 1 AC8 6 ARG B 570 ARG B 627 THR B 657 ASN B 659
SITE 2 AC8 6 ARG B 661 HOH B 902
SITE 1 AC9 7 SER B 597 VAL B 601 PHE B 694 ASN B 724
SITE 2 AC9 7 CYS B 725 THR B 726 LEU B 729
SITE 1 BC1 3 GLN B 574 ASN B 659 ARG B 661
SITE 1 BC2 1 PRO B 578
SITE 1 BC3 4 PRO B 466 ILE B 529 GLU B 533 THR B 552
SITE 1 BC4 3 GLY A 703 VAL A 704 GLU B 708
SITE 1 BC5 15 LEU B 484 GLU B 486 ALA B 512 LYS B 514
SITE 2 BC5 15 GLU B 531 VAL B 561 GLU B 562 TYR B 563
SITE 3 BC5 15 ALA B 564 SER B 565 GLY B 567 LEU B 630
SITE 4 BC5 15 PHE B 642 HOH B 960 HOH B 981
CRYST1 210.713 50.365 65.641 90.00 106.67 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.004746 0.000000 0.001421 0.00000
SCALE2 0.000000 0.019855 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015903 0.00000